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Abstract Hepatitis C virus (HCV) replicon systems
enable in-depth analysis of the life cycle of HCV. How-
ever, the previously reported full-genome replicon system
is unable to produce authentic virions. On the basis of these
results, we constructed newly designed full-genomic rep-
licon RNA, which is composed of the intact 50-terminal-
half RNA extending to the NS2 region ﬂanked by an extra
selection marker gene. Huh-7 cells harboring this full-
genomic RNA proliferated well under G418 selection and
secreted virion-like particles into the supernatant. These
particles, which were round and 50 nm in diameter when
analyzed by electron microscopy, had a buoyant density of
1.08 g/mL that shifted to 1.19 g/mL after NP-40 treatment;
these ﬁgures match the putative densities of intact virions
and nucleocapsids without envelope. The particles also
showed infectivity in a colony-forming assay. This system
may offer another option for investigating the life cycle of
HCV.
Introduction
Hepatitis C virus (HCV) is a major cause of chronic hep-
atitis, liver cirrhosis, and hepatocellular carcinoma. With
over 170 million people currently infected [2], HCV is a
growing public-health burden.
The life cycle of HCV has been difﬁcult to study
because cell culture and small animal models of HCV
infection are not available. The recent development of
HCV replicon systems has permitted the study of HCV
translation and RNA replication in human hepatoma-
derived Huh-7 cells in vitro [17]. However, these replicon
systems cannot produce authentic virions because they lack
the infection steps, and analysis of these infection steps is
very important for understanding HCV pathogenesis.
Recently, some groups have successfully established in
vitro infection systems [16, 21, 26, 28–30]. The strategies of
these systems are basically the same as the ones used for
transfection of Huh-7 cells or their derivatives with in vitro-
generated HCV genome RNA [1]. The non-structural
regions used inthose studies were from the 2a genotype JFH
(Japan Fulminant Hepatitis)-1 clone or the 1a genotype H77
clone. The former is known for its exceptionally vigorous
ampliﬁcation and broad permissiveness in cultured cells
otherthanHuh-7[3,12,13],whilethelattershowsonlypoor
replication ability. Another group reported a newly estab-
lishedimmortalizedhepatocytecelllinethatissusceptibleto
HCV infection, but only modest improvement was achieved
[10]. There are also reports of a system using a full-genome
repliconthathastheentirecodingregionunderthecontrolof
the internal ribosomal entry site of encephalomyocarditis
virus, EMCV-IRES; however, this system also failed to
show infectivity in the G418 selection assay [7, 20], and
secretion of particles with the putative characteristics of
HCV virions could not be conﬁrmed [4].
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Arch Virol (2011) 156:295–304
DOI 10.1007/s00705-010-0859-xWe now report the establishment of infectious virion-
producing replicon cells that utilize an ordinary genotype
1b replicon strain. In order to address the contribution of
structural and non-structural gene products to the matura-
tion of HCV particles in vitro, we partitioned these regions
in the same cistron of the full genomic sequence, thereby
enabling the functions of these structural and non-structural
genes to be studied separately. Thus, we termed this con-
struction ‘‘divided open reading frame carrying’’ full gen-
ome replicon, or dORF replicon.
Virus particles secreted from cells containing dORF
replicon RNA, as conﬁrmed morphologically using elec-
tron microscopy, were shown to be able to infect Huh-7
cells. Replication of dORF replicon RNA was so efﬁcient
that infected cells could survive and proliferate under G418
selection to form colonies, as seen after transfection with
replicon RNA. In addition, a reporter gene was successfully
inserted into the construct, and activity of the reporter gene
could be transmitted to naive Huh-7 cells by infection.
We believe that the success of this system is due to the
difference in the construction of the replicon, namely,
having the intact 50 half extending to NS2 instead of being
divided at the beginning of the core region. Although
further investigation is required to elucidate whether the
encapsidation signal of HCV is located in the region that is
divided in the full-genome replicon, this is the ﬁrst report
to describe genome-length replicon-containing cells that
can produce virus particles that have the putative charac-
teristics of the HCV virion, in terms of both morphology
and biological properties.
Results
dORF replicon RNA can replicate in Huh-7 cells
We began this study with transfection with the dORF
replicon RNAs (Fig. 1A). When 30 lg of each RNA was
electroporated into 4 9 10
6 Huh-7 cells, the dORF and
dORF bla RNA-transfected cells formed 20 and 5 colonies,
respectively, after 3 weeks of G418 selection. No colonies
appeared as a result of transfection with polymerase-
defective mutants (data not shown). Two colonies were
picked, ampliﬁed, and designated as dORF replicon cell #1
and #2, and dORF bla replicon cell #1 and #2. Some of
these cells were then used for quantiﬁcation of HCV RNA
and northern blot analysis (Fig. 1B). Northern blot analysis
showed that these clones contained HCV RNAs of the
expected size and that the HCV RNA copy numbers of
these clones did not differ substantially from that of the
subgenomic replicon, indicating that replication ability had
not been hampered by insertion of the structural genes,
which is counter to what was expected. Western blot
analysis showed that these clones express both structural
and non-structural proteins (Fig. 1C). These results con-
ﬁrmed that transfected dORF HCV RNAs can replicate in
Huh-7 cells, just as authentic subgenomic replicon RNAs
do.
dORF replicon cells secrete virus particles
In a previous study, HCV subgenomic replicon cells
secreted RNase-resistant subgenomic RNA into the cul-
ture supernatant [4, 7, 20]. We also detected a similar
amount of RNase-resistant HCV RNA in the culture
supernatant of our dORF replicon cells, as well as of the
subgenomic and full-genome replicon cells. These
supernatants showed no signiﬁcant differences in terms of
distribution of HCV RNA in buoyant density gradient
analysis (Figs. 2A, B, open square). In contrast, there was
a clear difference between these supernatants after NP-40
treatment. While almost all of the HCV RNA in the
supernatant of the subgenomic replicon cells was elimi-
nated by NP-40 treatment (Fig. 2A, ﬁlled triangle), there
remained a peak of HCV RNA at a density of 1.18 g/mL
in the supernatant of the dORF replicon cells (Fig. 2B,
ﬁlled triangle). These results were conﬁrmed in the same
experiment, using concentrated culture supernatant
(Figs. 2C, D). We also conﬁrmed the results of previous
reports [7, 20], which showed no genomic RNA resistant
to NP-40 treatment in the supernatant of full-genome
replicon cells (Fig. 2E). Secreted core proteins in the
concentrated supernatant showed a different density gra-
dient distribution compared to genomic RNA (Fig. 2F,
open circle) in that the core proteins were present at
densities of 1.1–1.2 g/mL, while HCV RNA was more
broadly distributed in the range of 1.06–1.22 g/mL. Thus,
HCV RNA and core proteins were not always associated
with each other. However, after NP-40 treatment, core
proteins were found only in the same fraction as HCV
RNA, at 1.19 g/mL (Fig. 2F, ﬁlled triangle). Taken
together with the results of the report mentioned above
[20], our replicon cells harboring dORF RNA appeared to
secrete particles with core proteins that were assembled
into nucleocapsids as well as particles without core pro-
teins that were sensitive to NP-40 treatment, like the ones
from subgenomic and full-genome replicon cells. We
concluded that the broader distribution of the HCV gen-
ome RNA in the density gradient than that of the core
protein was caused by the overlapping distribution of
these two particle types, and that the remaining peaks of
genome RNA and core protein after NP-40 treatment
were of nucleocapsids that had had their envelopes
stripped off by NP-40 [11].
According to our hypothesis, the distribution of core
proteins in the density gradient represented that of the
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123intact virion, and we therefore tried to observe virions
directly by electron microscopy, using the fraction in which
the core protein was present. We easily identiﬁed numerous
round-shaped virus particles approximately 50 nm in
diameter by scanning electron microscopy (Fig. 3A). Fur-
thermore, when the immunogold method using anti-E2
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Fig. 1 Conﬁrmation of
‘‘divided open reading frame
carrying’’ (dORF) replicon
cells. (A) Schematic
representations of replicon
RNAs used in this study. All the
replicon constructs contained
inserts just after the T7
promotor. UTR, untranslated
region; NS, non-structural
protein; neo, neomycin
phosphotransferase II; EMCV,
encephalomyocarditis virus;
IRES, internal ribosomal entry
site; FMDV, foot-and-mouth
disease virus; bla, beta-
lactamase. (B) Northern blot
analysis. A 10-lg amount of
total RNA from each cell
sample was loaded. Subgenomic
replicon RNA: 10
8 copies of in
vitro-generated subgenomic
RNA. Numbers below the lanes
are the HCV copy number per
microgram of total RNA. Huh-7
cell, subgenomic replicon cell,
dORF replicon cell #1, #2,
dORF bla replicon cell #1, #2.
(C) Western blot analysis. A
10-lg amount of each cell lysate
was loaded. Huh-7 cell, Huh-7-
JFH1: Huh-7 cell transfected
with JFH1 viral RNA,
subgenomic replicon cell, full-
genome replicon cell, dORF
replicon cell #1, #2, dORF bla
replicon cell #1, #2
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123RR6 antibody was applied to samples ﬁxed on the mesh,
transmission electron microscopy could be used to visual-
ize virus particles labeled with colloidal gold (Fig. 3B).
These ﬁndings provide evidence of intact virion production
from our dORF replicon cells.
Secreted virus particles can infect naive Huh-7 cells
Next, we examined the infectivity of these virus particles.
The culture supernatants of these dORF replicon cells were
collected, and 3 kinds of naive Huh-7 cells, one purchased
from the J.C.R.B. (Japanese Collection of Research Bio-
resources) and the other two, designated as the cured cells
F2 and K4, generated by IFN-a treatment of 1bneo/delS
replicon cells, were infected with these supernatants. After
two sequential passages and three weeks of G418 selection
as described above, a number of colonies appeared, as
shown in Fig. 4A. The largest number of colonies was
produced from the cured cells K4, and slightly fewer col-
onies were produced from the cured cells F2, while no
colonies appeared when normal Huh-7 cells were used
(data not shown). The same infection experiment carried
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Fig. 2 Density gradient analysis of supernatants. Culture superna-
tants were treated with RNaseA and loaded directly onto a sucrose
density gradient without treatment (open square) or after NP-40
treatment (ﬁlled triangle). Quantiﬁcation of HCV RNA in each
fraction of supernatant from the subgenomic replicon (A) and dORF
replicon (B). Analysis of concentrated culture supernatant from the
subgenomic replicon (C) and dORF replicon (D). Concentrated
culture supernatant from the full-genome replicon NNC#2 was also
analyzed (E). Quantiﬁcation of HCV core protein in each fraction of
supernatant from the dORF replicon (F)
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123out with full-genome replicon cells produced no infectivity
in the supernatant (data not shown). Under the most efﬁ-
cient conditions, the titer of the supernatant reached as high
as 20 cfu (colony-forming units) per milliliter when the
putative doubling time of these cells was approximately
24 h. Furthermore, the appearance of colonies was abol-
ished by addition of the antibody JS-81 (BD Pharmingen),
an antibody to CD81, a possible co-receptor of HCV [22]
(Fig. 4B).
Next, we propagated some of these colonies for further
analysis. Northern blot analysis showed that these clones
carry HCV RNAs of reasonable size (Fig. 5A), including
subgenomic RNA (7994 bases), dORF RNA (10994 bases),
and dORF bla RNA (11840 bases). Western blot analysis
revealed that the cell clones that were infected with
supernatant from Huh-7 cells containing the dORF replicon
expressed structural proteins (Fig. 5B), indicating that the
colonies were not just the reappearance of subgenomic
replicons hidden in the cured cells.
Together, our ﬁndings indicate that these particles in the
supernatant infected the Huh-7 cells through a CD81-
associated pathway and that infected cells formed colonies
after G418 selection, similar to what was observed with
electroporation with subgenomic RNA.
A reporter gene inserted into the dORF replicon RNA
can be transmitted through infection
First, we conﬁrmed that the beta-lactamase gene in the
dORF bla replicon RNA was active in established replicon
cell clones and able to process the green ﬂuorescent sub-
strate into blue ﬂuorescent product (Fig. 6A). Next, we
attempted to detect the activity of the beta-lactamase gene
in the cloned infected colonies. Three clones grown from
cells infected with the dORF bla supernatant were treated
using a GeneBLAzer In Vivo Detection Kit. One clone was
positive for blue ﬂuorescence (Fig. 6B), demonstrating that
a reporter gene inserted into the dORF replicon could be
transmitted to naive Huh-7 cells through secreted virus
particles in the culture supernatant.
Discussion
There have been several previous reports of full-genome
HCV replicons that can replicate well in Huh-7 cells and
express sufﬁcient amounts of structural proteins [1, 4, 7,
14, 20]. Pietschmann et al. (2002) observed the secretion of
an RNase-resistant HCV genome into the supernatant from
both full-genome and subgenomic replicon cells and non-
speciﬁc uptake of these genomes by naive Huh-7 cells.
Ikeda et al. (2002) were also unable to detect any infec-
tivity in the supernatant of their full-genome replicon cells.
They assumed that the reason for this failure was the
inability of Huh-7 cells to release intact virions or to be
infected by the virus, although this was later demonstrated
not to be the case by a series of reports on infection using
the JFH-1 clone [16, 26, 30].
First, we attempted to improve the efﬁciency of the full-
genome replicon in two ways, namely, by modifying the
construct and reducing the genome size. Numerous studies
have examined the encapsidation signal in the genomic
RNA of positive-sense single-stranded viruses [5, 8, 9].
Frolova et al. [5] showed that the encapsidation signal of
Sindbis virus lies in the nsP1 gene and is 132 nucleotides
long. Johansen et al. [9] found that the IRES of poliovirus
had the ability to enhance the efﬁciency of packaging of
the polio subgenomic replicon. We think that these ﬁndings
indicate that the construction of the genome could affect
the efﬁcacy of encapsidation, and we therefore decided to
Fig. 3 Electron microscopy analysis of virus-like particles. The core-
protein-rich fraction collected from the density gradient was further
concentrated by ultracentrifugation and observed by scanning electron
microscopy (A). The same fraction attached to formvar-coated grids
was incubated with rabbit anti-E2 RR6 antibody, treated with goat
anti-rabbit IgG coupled to 10-nm colloidal gold, negatively stained
with uranyl acetate, and then examined by transmission electron
microscopy (B)
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123change the site of genome division from the beginning of
the core region to the middle of the NS2 region. Regarding
the size of the genome, there have been reports that the
insertion of a foreign gene of signiﬁcant size can result in
the deletion of a portion of the chimeric genome during
replication [18, 19]. We therefore removed the second half
of the NS2 region, because this region appears to be
unnecessary for both replication and packaging in Huh-7
cells, and this deletion was found to have no inﬂuence on
the efﬁcacy of encapsidation, as there were no apparent
differences between the NS2-deleted construct and the one
containing the entire NS2 region (data not shown).
Our established dORF replicon was able to replicate
well in Huh-7 cells and express sufﬁcient amounts of
structural proteins, similar to the previously reported full-
genome replicon. Although both the dORF replicon cells
and the previously reported full-genome replicons secreted
RNase-resistant genomes, there was a striking difference
between these two full-genome replicons when NP-40
treatment was carried out on their supernatants. There was
no RNase-resistant genome left in the NP-40-treated
supernatant of full-genome replicons, although density
gradient analysis of the NP-40-treated supernatant of dORF
replicon cells clearly showed the coexistence of the HCV
genome and core proteins at a peak of 1.18 g/mL. This
peak may represent NP-40-resistant nucleocapsids. The
distribution of core proteins in the density gradient analysis
of the concentrated supernatant of the dORF replicons did
not match that of the HCV genome. A reasonable expla-
nation for this mismatch is that the lighter side of the broad
peak of the HCV genome was not representative of intact
virions and is instead an indication of secretion by a
pathway used in subgenomic replicon cells, which differs
from the natural process. The fact that the peak of the HCV
genome of full-genome replicons was located in a narrow
range on the lighter side compared to that of the dORF
replicons supports this hypothesis. We observed round
particles in the concentrated core protein fraction using
electron microscopy, and those particles also seemed to
contain core proteins. These ﬁndings indicate that our
dORF replicon cells produced both intact virions and
artiﬁcial membranous particles, with the former having the
morphological and biophysical characteristics of putative
virions.
The colony-forming assay clearly demonstrated the
ability of the supernatants of our dORF replicon cells to
infect Huh-7 cells efﬁciently. The reason for the difference
in efﬁcacy between the two cured cells is uncertain but may
involve the ability to support replication or the level of
receptor expression. This needs to be clariﬁed in order to
improve the efﬁciency of HCV infection in vitro. Differ-
ences in the efﬁciency of infection were also noted between
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123clones of the same dORF replicon cells, which may have
been due to the accumulation of different mutations in the
structural region, although we have not yet conﬁrmed this
hypothesis. We also observed colonies being formed by
cells that were treated with supernatant containing subge-
nomic replicons, and these colonies most likely represent
the so-called ‘‘non-speciﬁc transduction’’ of the subge-
nomic replicon. Although this dORF supernatant infection
could be blocked by the anti-CD81 antibody reported
previously [30], we cannot exclude the possibility that the
infection we observed was due to highly efﬁcient ‘‘non-
speciﬁc transduction,’’ as we could not determine whether
‘‘non-speciﬁc transduction’’ also could be affected by the
anti-CD81 antibody because of the low colony-forming
ability of the supernatant of subgenomic replicons.
We also demonstrated that the reporter gene that was
inserted in addition to the neomycin resistance gene could
be transmitted to the new generation of viruses. This
ﬁnding raises the possibility of producing sufﬁcient
amounts of reporter virus constitutively.
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Fig. 5 Northern blot analysis of colonies formed after infection. 10
7,
10
9: amounts of in vitro-generated subgenomic replicon RNA loaded.
Numbers below the lanes are the HCV copy number per lg of total
RNA (A). Huh-7 cells, subgenomic replicon cells, dORF replicon cell
#2, dORF bla replicon cell #2, subgenomic replicon sup: colony from
cells transduced with subgenomic replicon supernatant, colony No.1,
2 of dORF replicon #2 sup: colonies from cells infected with dORF
replicon #2 supernatant, colony No.1, 2, and 3 of dORF bla replicon
#2 sup: colonies from cells infected with dORF bla replicon #2
supernatant. Western blot analysis of colonies formed after infection
(B). The order of the lanes is identical to that for the northern blot,
except for the dORF and dORF bla replicons, which represent two
clones in this ﬁgure
Fig. 6 Detection of beta-lactamase activity in dORF replicon cells.
Parental dORF bla replicon #2 cell (A) and colony no. 3 cloned from
cells infected with dORF bla replicon #2 cell supernatant (B). Blue
ﬂuorescence shows high beta-lactamase activity, indicating that the
reporter gene functioned normally after infection
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123In summary, we established an infectious-particle-pro-
ducing HCV replicon system. This achievement should
yield more precise information about the encapsidation
signal of HCV, which was kept intact despite the parti-
tioning of the genome. This system also allows analysis of
the pathway of HCV infection, including adsorption of
virions to cell-surface receptors, penetration, uncoating,
virus particle assembly, and HCV release. Moreover, the
dORF replicon system may be used as a convenient tool to
investigate the utility of the newly established siRNA
system [14, 27] and evaluation of compounds that are
effective against subgenomic replicons.
Although we believe that the reason for our success is
our new construct, further examination is necessary to
verify our ﬁndings.
Materials and methods
Construction and RNA transcription
To construct dORF replicon RNA, the second half of the
NS2 region of the HCV-R6 strain [25] was replaced in
frame with the foot and mouth disease virus (FMDV) 2A
protease gene, the neomycin resistance gene, and the en-
cephalomyocarditis virus (EMCV) internal ribosomal entry
site (IRES). In addition, the region from NS3 to the
beginning of NS5B was replaced with the 1bneo/delS
replicon sequence from the N strain of genotype 1b
[6](kindly provided by Dr. Seeger). This construct was
designated as the ‘‘divided open reading frame carrying full
genome’’ (dORF) replicon. The subgenomic replicon con-
struct was also prepared from the R6 strain and also con-
tained the 1bneo/delS replacement. For the reporter assay,
the FMDV 2A protease gene and beta-lactamase gene (bla;
Invitrogen) were inserted after the remaining NS2 gene to
produce the dORF bla replicon construct. Replication-
deﬁcient versions of these three replicons were also pre-
pared by deleting 27 nucleotides, including the GDD motif
of NS5B polymerase.
In vitro transcription of these replicon RNAs was per-
formed using the MEGAscript kit (Ambion).
Cell culture and electroporation
Huh-7 cells were cultured in DMEM (SIGMA) with 10%
fetal bovine serum. Replicon cells were maintained in
the same medium supplemented with 300 lg/mL G418
(Invitrogen). These cells were passaged 3 times a week at a
4:1 splitting ratio. Electroporation of replicon RNA was
performed as described previously [17]. The subgenomic
replicon (1bneo/delS replicon) cells were treated with
1000 IU of IFN-a for 2 months and cloned by the limited
dilution method. Two of these clones were designated as
HCV replicon-cured Huh-7 cells F2 and K4. The cell line
containing the full-genome replicon of genotype1b, namely
the NNC#2 clone [15], was a kind gift from Dr. Shim-
otohno of Keio University.
Northern blot analysis and quantiﬁcation of HCV RNA
Total RNA was puriﬁed from cells using ISOGEN (Nippon
Gene) for northern blot analysis or ABI prizm6100
(Applied Biosystems) for real-time RT-PCR. Puriﬁed
RNAs were quantiﬁed by absorbance at 260 nm. For
northern blot analysis, 30 lg of each total RNA was used
with a Northern Max Kit (Ambion) according to the
manufacturer’s instructions. The probe for detection of
HCV RNA was a PCR fragment of the NS5B region
(nucleotide numbers 7629–7963) that had been biotin-
labeled using a BrightStar Psoralen-Biotin Kit (Ambion)
according to the manufacturer’s instructions. Following
hybridization of the membranes, the probe was detected
using a BrightStar BioDetect Kit (Ambion) according to
the manufacturer’s instructions, and luminescence was
detected using the LAS1000 detection system (Fujiﬁlm).
Measurement of the HCV RNA copy number by real-time
RT-PCR was performed using an ABI PRISM 7900 system
(Applied Biosystems) as described previously [24].
Western blot analysis
Western blot analysis was carried out using the conven-
tional semi-dry blot method. Cells were lysed with buffer
containing 100 mM Tris-HCl (pH 7.4) and 4% sodium
dodecyl sulfate. A 10-lg amount of protein from each
sample was separated by SDS-PAGE through a 4–20%
gradient gel (Invitrogen) and transferred to the membrane
according to the gel manufacturer’s protocol. The anti-
bodies used in this study were anti-core mouse monoclonal
antibody (MAb), anti-E1 MAb, anti-E2 MAb (reported
previously; [25]), anti-NS3 antiserum (reported previously;
[25]), anti-NS5B antiserum (Upstate), and anti-beta-actin
MAb (Abcam). Horseradish peroxidase-labeled anti-mouse
and anti-rabbit IgG goat antibodies (Santa Cruz Biotech-
nology and DAKO, respectively) were used as the sec-
ondary antibody. The membranes were treated using an
ECL Plus kit (Amersham) according to the manufacturer’s
instructions, and luminescence was detected using an
LAS1000 system (Fujiﬁlm).
Density gradient analysis and core ELISA
Culture supernatants from replicon cells were loaded onto
10–60% sucrose density gradient tubes with or without
10-fold concentration in an Amicon-100 (Millipore). The
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123tubes were then ultracentrifuged at 100,000 g for 16 h and
fractionated. NP-40 was added to the culture supernatants
to a ﬁnal concentration of 0.5%, and they were then
incubated at 4C for 30 min. For electron microscopy, the
culture supernatant was concentrated, loaded onto a 60%
sucrose cushion, and ultracentrifuged at 100,000 g for 4 h.
The interface between the concentrated medium and the
sucrose cushion was collected and separated by the den-
sity gradient method described above. A 2-mL fraction
from 5 ml to 7 mL from the bottom, with a density of
1.1–1.2 g/mL, was examined by electron microscopy after
further concentration by the sucrose cushion ultracentrifu-
gation method described above. The amount of core protein
in the fractions was quantiﬁed using an Ohso ELISA kit in
accordance with the manufacturer’s instructions.
Electron microscopy
The concentrated fraction of core protein was observed by
scanning and transmission electron microscopy. For scan-
ning electron microscopy, the sample was allowed to settle
on the surface of a poly-L-lysine-coated glass cover slip for
30 min, and the attached sample was then ﬁxed with 0.1%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for
10 min, washed three times with 0.1 M phosphate buffer,
and post-ﬁxed with 1% osmium tetroxide in the same
buffer for 10 min. After dehydration through a graded
series of ethanol, the samples were dried in a freeze dryer
(Hitachi ES-2020, Hitachi) using t-butyl alcohol, coated
with osmium tetroxide, approximately 2 nm thick, using an
osmium plasma coater (NL-OPC80; Nippon Laser and
Electronics Laboratory), and then examined using a Hitachi
S-4800 ﬁeld emission scanning electron microscope at an
accelerating voltage of 10 kV [23]. For transmission
electron microscopy, the sample was allowed to settle on a
formvar-coated nickel grid for 10 min, dried in air, incu-
bated with rabbit anti-E2RR6 antibody (prepared as
described in the supplementary information), washed with
PBS, and then incubated with goat anti-rabbit IgG coupled
to 10-nm colloidal gold (British BioCell). After negative
staining with 2% uranyl acetate, the sample was examined
using a JEM 1200EX transmission electron microscope
(JEOL) at an accelerating voltage of 80 kV.
Rabbit anti-E2 RR6 antibody to the HCV-E2 protein
was prepared as follows: The E2 gene of HCV type 1b
[25] was cloned under the control of the ATI-P7.5 hybrid
promoter of vaccinia virus vector pSFB4 and allowed to
recombine with the Lister strain of the vaccinia virus to
give vector RVV. Rabbits were infected intradermally
with 10
8 p.f.u. of RVV, and 2 months later, they received
two booster injections with the puriﬁed E2 protein.
HCV-E2 protein was expressed from the RVV vector
and puriﬁed by lentil lectin column chromatography and
afﬁnity chromatography using an anti-E2 monoclonal
antibody [25].
Infection
A 2.5-ml aliquot of cleared culture supernatants from
replicon cells was added to approximately 70% conﬂuent
of Huh-7 cells in 25-cm
2 ﬂasks, and the same amount of
complete DMEM was added 2 h later. Infected cells were
transferred to 75-cm
2 ﬂasks the next day and to four 10-cm
dishes 2 days later. G418 at a concentration of 300 lg/mL
was added to the medium immediately after the second
passage. The three types of Huh-7 cells used in this study
included the one purchased from J.C.R.B. and the 2 IFN-
cured replicon cell lines F2 and K4 described above. The
medium was changed every other day. For the blocking
experiment, cells were treated with the anti-CD81antibody
as described previously [30]. Cells were ﬁxed with 10%
formalin/PBS(-) for 10 min after washing with PBS(-) and
staining with 1% crystal violet/PBS(-) for 1 h before
washing with water.
Beta-lactamase detection assay
Beta-lactamase activity was detected using a GeneBLAzer
In Vivo Detection Kit (Invitrogen) according to the man-
ufacturer’s instructions and observed using a ﬂuorescence
microscope (Nikon) with UV light excitation.
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